We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
301
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.05M 0.07%
280,000
+103,000
+58% +$1.59M
PBYI icon
302
Puma Biotechnology
PBYI
$406M
$4.05M 0.07%
41,000
-16,500
-29% -$1.85M
ALK icon
303
Alaska Air
ALK
$5.15B
$4.03M 0.07%
54,762
-84,317
-61% -$6M
ENTA icon
304
Enanta Pharmaceuticals
ENTA
$372M
$3.99M 0.07%
68,000
-157,000
-70% -$7.86M
AABA
305
DELISTED
Altaba Inc
AABA
$3.98M 0.07%
56,984
-26,063
-31% -$1.81M
ANAB icon
306
AnaptysBio
ANAB
$1.6B
$3.98M 0.07%
+39,500
New +$2.91M
WMT icon
307
Walmart Inc
WMT
$871B
$3.93M 0.07%
119,433
-4,308
-3% -$132K
LULU icon
308
lululemon athletica
LULU
$13B
$3.92M 0.07%
49,877
-8,397
-14% -$560K
MIC
309
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$3.91M 0.07%
60,971
-85,675
-58% -$5.8M
LRCX icon
310
Lam Research
LRCX
$382B
$3.91M 0.07%
212,470
+69,010
+48% +$1.36M
EBAY icon
311
eBay
EBAY
$48.6B
$3.88M 0.07%
102,789
+1,827
+2% +$67.8K
KPTI icon
312
Karyopharm Therapeutics
KPTI
$168M
$3.87M 0.07%
26,867
-7,133
-21% -$1.15M
D icon
313
Dominion Energy
D
$62.5B
$3.85M 0.07%
47,439
+4,885
+11% +$396K
BNS icon
314
Scotiabank
BNS
$106B
$3.81M 0.07%
58,828
+7,040
+14% +$456K
KMB icon
315
Kimberly-Clark
KMB
$36.4B
$3.79M 0.07%
31,416
-7,049
-18% -$822K
ROP icon
316
Roper Technologies
ROP
$36.3B
$3.73M 0.06%
14,399
+4,406
+44% +$1.13M
TTWO icon
317
Take-Two Interactive
TTWO
$43B
$3.73M 0.06%
33,941
-54,506
-62% -$5.95M
ZTS icon
318
Zoetis
ZTS
$31.6B
$3.69M 0.06%
51,285
+122
+0.2% +$8.38K
AIG icon
319
American International
AIG
$41.9B
$3.69M 0.06%
61,852
-1,507
-2% -$92.6K
CME icon
320
CME Group
CME
$92.2B
$3.67M 0.06%
25,110
+1,393
+6% +$198K
IMGN
321
DELISTED
Immunogen Inc
IMGN
$3.65M 0.06%
570,000
LH icon
322
Labcorp
LH
$24.3B
$3.61M 0.06%
26,363
-879
-3% -$116K
BAX icon
323
Baxter International
BAX
$11.6B
$3.58M 0.06%
55,419
-16,635
-23% -$1.07M
CSX icon
324
CSX Corp
CSX
$98.6B
$3.57M 0.06%
194,571
+3,252
+2% +$57.6K
KHC icon
325
Kraft Heinz
KHC
$30.4B
$3.57M 0.06%
45,827
-1,451
-3% -$114K

Similar funds

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.